Table of Content




1. Executive Summary


2. Global Nucleic Acid Testing Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Nucleic Acid Testing Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Nucleic Acid Testing Market by Product Type
3.3.1: Polymerase Chain Reaction
3.3.2: Ligase Chain Reaction
3.3.3: Transcription–mediated Amplification
3.3.4: Whole Genome Sequencing
3.3.5: Others

3.4: Global Nucleic Acid Testing Market by Indication
3.4.1: Infectious Disease
3.4.2: Cancer
3.4.3: Forensic Testing
3.4.4: Personalized Medicine
3.4.5: Others

3.5: Global Nucleic Acid Testing Market by End Use
3.5.1: Hospitals & Clinics
3.5.2: Pathology Laboratories
3.5.3: Academic & Research Organization
3.5.4: Others




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Nucleic Acid Testing Market by Region
4.2: North American Nucleic Acid Testing Market
4.2.1: North American Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
4.2.2: North American Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others

4.3: European Nucleic Acid Testing Market

4.3.1: European Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
4.3.2: European Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others

4.4: APAC Nucleic Acid Testing Market

4.4.1: APAC Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
4.4.2: APAC Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others

4.5: ROW Nucleic Acid Testing Market

4.5.1: ROW Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
4.5.2: ROW Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Nucleic Acid Testing Market by Product Type
6.1.2: Growth Opportunities for the Global Nucleic Acid Testing Market by Indication
6.1.3: Growth Opportunities for the Global Nucleic Acid Testing Market by End Use

6.1.4: Growth Opportunities for the Global Nucleic Acid Testing Market by Region

6.2: Emerging Trends in the Global Nucleic Acid Testing Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Nucleic Acid Testing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic Acid Testing Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: F. Hoffmann-La Roche
7.2: Becton and Dickinson
7.3: Danaher
7.4: Abbott Laboratories
7.5: Illumina
7.6: Siemens Healthineers
7.7: bioM?rieux